search.noResults

search.searching

note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
The latest Business updates from the science industry


Ingenza Celebrates EU H2020 SME Instrument Success by Heather Hobbs


Ingenza is pleased to announce it has successfully applied for EU H2020 SME Instrument funding of €50,000 for Phase 1 of its innovative SYNBIOMAN project, allowing the company to forge ahead with the development of this novel synthetic biology-driven biomanufacturing platform.


Successful completion of the Phase 1 study could open the door to additional funding for Phase 2, valued at €2.5 million. SYNBIOMAN will build on Ingenza’s proprietary industrial synthetic and systems biology tools, helping small and medium-sized biotechnology enterprises to close the gap from lab to market by developing GMP biomanufacturing capabilities that target the production of therapeutic proteins.


Frequently, these drug candidates are sourced from low yielding organisms, have highly complex structures, or are very toxic.


As a result, they can be challenging to manufacture, preventing the development of new therapies for currently unmet clinical needs. Dr David McElroy, Chief Business Offi cer at Ingenza, said: “We are delighted to have secured EU H2020 SME Instrument support for this project.


The Horizon 2020 programme receives thousands of funding


applications each year, and fewer than fi ve per cent of applicants are successful. It is a real achievement for our scientifi c research to be recognised in this way.” For more information, visit www.ingenza.com


40882pr@reply-direct.com


Ocean Optics Appoints Two New Executives


Ocean Optics, the industry leader in modular spectroscopy applications and products, has appointed two new board members. Jack Riccardi has joined the company as vice president fi nance, and David Schaefer has taken on the vice president sales and strategic marketing role. Riccardi is responsible for all aspects of fi nance, accounting, IT and offi ce administration at Ocean Optics. Schaefer is responsible for the global sales and marketing of the company’s entire line of spectrometers, chemical sensors, analytical instrumentation and accessories. Both are members of the executive board, assisting in the strategic management of the company’s business, including sales, operations, engineering, and fi nance. Riccardi joins Ocean Optics from MDNA Life Sciences, where he was chief fi nancial offi cer. He has a strong background in fi nancial controls, governance and risk management. Riccardi holds a Bachelor of Science in Accounting from Pennsylvania State University, an MBA from the University of Pennsylvania Wharton School of Business and an MS in Operations Science from the London School of Economics and Political Science. Schaefer joins Ocean Optics from AxelaCare, where he was chief marketing offi cer. He has extensive experience in the execution of growth-based commercial plans, strategic planning and business transformation. Schaefer holds a Bachelor of Science in Chemical Engineering from Johns Hopkins University and an MBA from the Northwestern University Kellogg School of Business.


Jack Riccardi 41116pr@reply-direct.com David Schaefer


William Linton is New Member of the Supervisory Board of Eppendorf AG


On 9 January 2017, William A. Linton was elected as a member of the Supervisory Board of Eppendorf AG, Hamburg, during an extraordinary Shareholders’ Meeting.


“With William Linton, we are very pleased to welcome a successful entrepreneur and experienced manager from the life science sector to our Supervisory Board,” stated Philipp von Loeper, Chairman of the Supervisory Board of Eppendorf AG.


William Linton founded Promega Corporation in 1978 and has served since then as its Chairman and Chief Executive Offi cer. Headquartered in Madison, Wisconsin, USA, Promega is a global life science research and diagnostics products company and employs over 1,400 people worldwide.


41464pr@reply-direct.com


Anton Paar Purchases Future-oriented Raman Technology from Silicon Valley


The signing of the contract in Graz: CEO of BaySpec Inc William Yang (left) and Nils Bertram, General Manager of Anton Paar OptoTec GmbH.


As of 1 December 2016, Anton Paar has purchased a Raman spectroscopy product line from BaySpec Inc. The product line, consisting of two Raman spectrometers and one Raman microscope, will be implemented and further developed in a new product department at Anton Paar OptoTec GmbH in Seelze. In addition, Anton Paar licensed technology for handheld Raman technology from SciAps Inc located in Massachusetts. Nils Bertram, General Manager Anton Paar OptoTec GmbH: “From both a business and a technological point of view, this purchase of products and technology represents a future-oriented step for Anton Paar in Seelze, Germany. We have now entered the fi eld of molecular spectroscopy.” The two Raman spectrometers and the Raman microscope round off the company’s portfolio for the pharmaceutical and chemical industries. The measuring instruments are available with immediate effect.


41206pr@reply-direct.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88